- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02124343
Exercise and Neutrophil Function in COPD
A Pilot Study to Examine the Effect of Acute Exercise on Neutrophil Function in Patients With Chronic Obstructive Pulmonary Disease
Exercise is a cornerstone of pulmonary rehabilitation in the treatment of Chronic Obstructive Pulmonary Disease (COPD). Although researchers have shown numerous benefits with exercise in COPD patients, most studies have only looked at exercise tolerance and psychological outcomes following training. COPD is characterised by persistent inflammation that can cause progressive decline in lung function and multisystemic complications. This inflammation can be amplified in patients when they suffer acute exacerbations. There is a wellknown relationship between exercise, immune function and risk of infection. Exercise has also been shown to have an antiinflammatory effect when performed regularly. There is a lack of research looking into the inflammatory or immune response to exercise in patients with COPD. The exercise within this study will be individually tailored to patients with COPD based on their validated 6 minute walk test (6MWT) but the protocol will involve interval exercise that has been used previously. This type of exercise is considered most appropriate for research into mechanisms of benefit because it maintains the exercise training effects of other modalities (e.g. continuous low intensity aerobic exercise) while avoiding the occurrence of limitations to exercise in people with lung problems (e.g. dynamic hyperinflation). It also closely mirrors daily activity of someone with COPD.
The investigators want to explore the effects of exercise specifically on immune function in 15 people COPD and compare any changes to 15 Controls. By better understanding the mechanisms of how exercise affects inflammation, the investigators could eventually design better Pulmonary Rehabilitation interventions, especially for those most at risk.
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Carmarthenshire
-
Llanelli, Carmarthenshire, Regno Unito, SA14 8QF
- Prince Philip Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- COPD group - 15 Participants who have been diagnosed with any severity of COPD (according to BTS criteria, i.e. >10 pack-year smoking history and post-bronchodilator spirometry FEV1/FVC ratio <0.70 and FEV<80%) and have completed at least 12 from 18 sessions of a pulmonary rehabilitation programme.
- Age 50-80 years.
- Current non-smoker.
- Control group - 15 Participants who will act as Controls, without COPD or cardiovascular disease
- Age 50-80 years (ideally of similar gender distribution)
- Current non-smoker.
- Spirometry: FEV1/FVC>0.7 and FEV>80% predicted
Exclusion Criteria:
- Known asthma or allergic rhinitis or other respiratory disease (bronchiectasis, pulmonary fibrosis).
- A change in any medications within 4 weeks or during the study.
- Require domiciliary oxygen.
- Acute exacerbation of COPD within 4 weeks of study entry.
- Any infection or illness within 4 weeks of study entry.
- Other active inflammatory conditions e.g. rheumatoid arthritis, cancer, unstable cardiac conditions.
- Receiving oral steroids or other immunomodulating drugs.
- Currently undergoing exercise training (including Pulmonary Rehabilitation).
- Any previous cardiovascular contraindications to exercise (e.g. unstable angina).
- Inability to complete the 6MWT due to physical or mental impairment.
- Exhaled CO>10ppm or smoked any cigarettes within 6 months.
- Inability or unwillingness to sign informed consent.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Interval Exercise
Subjects will undertake an interval exercise session (on a harnessed treadmill) (HP Cosmos Mercury 4.0, HP Cosmos Sports and Medical Gmbh, Nussdorf-Traustein,Germany) based on the average speed calculated from the 6 minute walk test (6MWT). Intervals are based on the work previously done by Mador et al., 2009 who used intervals of 150% (for 1 minute) followed by intervals of 75% (for 2 minutes) based on 80% average speed from the 6 minute walk test. This study repeated these intervals 7 times with a duration of 23 minutes in total for the exercise intervention with the 75% intervals at the start and at the end of the exercise session. No warm up was undertaken for this method as it was a walking exercise test and the risk of injury was minimised with use of the harnessed treadmill. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Neutrophil response to exercise
Lasso di tempo: 4 months
|
The primary outcome measure for this study is to examine neutrophil responses to acute exercise, including changes in the counts and function of these cells in blood and sputa in order to compare any changes between COPD and age-gender matched controls.
|
4 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Different health status and the responses on neutrophil function
Lasso di tempo: 4 months
|
The secondary outcome measures for this study is to examine the responses of inflammatory (pro and anti) mediators (e.g.
cytokines) to acute exercise.
|
4 months
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Effect of inhaled steroids on neutrophil response following exercise
Lasso di tempo: 4 months
|
The third outcome for this study is to compare neutrophil response to exercise in those taking different types of inhaled steroid (fluticasone versus budesonide or beclamethasone).
|
4 months
|
|
Neutrophil response to exercise in past smokers versus non-smokers
Lasso di tempo: 4 months
|
The fourth outcome measure of this study is to compare neutrophil response to exercise in past smokers versus non-smokers.
|
4 months
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Alex R Jenkins, BSc (Hons), Aberystwyth University
- Cattedra di studio: Keir E Lewis, MD, Hywel Dda Health Board
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 14/WA/0022
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Interval Exercise
-
Rigshospitalet, DenmarkCompletatoDiabete mellito, tipo 2Danimarca
-
Institut d'Investigació Biomèdica de Girona Dr....Attivo, non reclutanteRiabilitazione | Infezione respiratoria da COVID-19 | FisioterapistiSpagna
-
Umeå UniversityRegion VästerbottenReclutamento
-
University of MinnesotaRitiratoSchizofrenia | Disturbo schizoaffettivo | PsicosiStati Uniti
-
Kuopio Research Institute of Exercise MedicineKuopio University Hospital; University of Basel; University of Eastern Finland; Social...TerminatoAngina pectoris instabile | Infarto miocardico acuto | Infarto miocardico ricorrenteFinlandia
-
University Hospitals Coventry and Warwickshire...University of Hull; Wake Forest University Health Sciences; University of Warwick; Bangor University e altri collaboratoriCompletatoMalattia coronaricaRegno Unito
-
California State University, San MarcosCompletatoMiglioramento del VO2max e della gittata cardiaca in risposta all'allenamentoStati Uniti
-
Chang Gung Memorial HospitalCompletatoFibrosi miocardica
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... e altri collaboratoriCompletatoArtrosi al ginocchioStati Uniti
-
Rigshospitalet, DenmarkReclutamentoBroncopneumopatia cronica ostruttivaDanimarca